Stockreport

Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference

Mineralys Therapeutics, Inc.  (MLYS) 
PDF RADNOR, Pa., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines [Read more]